Violetta Cotreau - Net Worth and Insider Trading

Violetta Cotreau Net Worth

The estimated net worth of Violetta Cotreau is at least $64,646 dollars as of 2024-11-13. Violetta Cotreau is the SVP, Chief Accounting Officer of Akebia Therapeutics Inc and owns about 33,067 shares of Akebia Therapeutics Inc (AKBA) stock worth over $64,646. Details can be seen in Violetta Cotreau's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Violetta Cotreau has not made any transactions after 2022-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Violetta Cotreau

To

Violetta Cotreau Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Violetta Cotreau owns 1 companies in total, including Akebia Therapeutics Inc (AKBA) .

Click here to see the complete history of Violetta Cotreau’s form 4 insider trades.

Insider Ownership Summary of Violetta Cotreau

Ticker Comapny Transaction Date Type of Owner
AKBA Akebia Therapeutics Inc 2022-01-03 SVP & Chief Accounting Officer

Violetta Cotreau Latest Holdings Summary

Violetta Cotreau currently owns a total of 1 stock. Violetta Cotreau owns 33,067 shares of Akebia Therapeutics Inc (AKBA) as of January 3, 2022, with a value of $64,646.

Latest Holdings of Violetta Cotreau

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKBA Akebia Therapeutics Inc 2022-01-03 33,067 1.96 64,646

Holding Weightings of Violetta Cotreau


Violetta Cotreau Form 4 Trading Tracker

According to the SEC Form 4 filings, Violetta Cotreau has made a total of 1 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 5,833 shares on January 3, 2022, which brought Violetta Cotreau around $13,358.

Insider Trading History of Violetta Cotreau

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Violetta Cotreau Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Violetta Cotreau Ownership Network

Ownership Network List of Violetta Cotreau

No Data

Ownership Network Relation of Violetta Cotreau

Insider Network Chart

Violetta Cotreau Owned Company Details

What does Akebia Therapeutics Inc do?

Who are the key executives at Akebia Therapeutics Inc?

Violetta Cotreau is the SVP & Chief Accounting Officer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & General Counsel & Sec. Nicole R. Hadas , and SVP & Chief Medical Officer Steven Keith Burke .

Akebia Therapeutics Inc (AKBA) Insider Trades Summary

Over the past 18 months, Violetta Cotreau made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 149,723 shares made by Michel Dahan , a net sale of 106,103 shares made by Steven Keith Burke , and a net sale of 88,587 shares made by Nicole R. Hadas .

In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 492,283 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,283 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akebia Therapeutics Inc Insider Transactions

No Available Data

Violetta Cotreau Mailing Address

Above is the net worth, insider trading, and ownership report for Violetta Cotreau. You might contact Violetta Cotreau via mailing address: 245 First Street, 14th Floor, Cambridge Ma 02142.